ASMB Stock Summary and Trading Ideas (Assembly Biosciences | NASDAQ:ASMB)

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Assembly Biosciences trades on the NASDAQ stock market under the symbol ASMB.

As of January 30, 2025, ASMB stock price climbed to $14.03 with 3,008 million shares trading.

ASMB has a beta of 0.97, meaning it tends to be less sensitive to market movements. ASMB has a correlation of 0.05 to the broad based SPY ETF.

ASMB has a market cap of $89.18 million. This is considered a Micro Cap stock.

Last quarter Assembly Biosciences reported $7 million in Revenue and -$1.51 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.51.

In the last 3 years, ASMB traded as high as $29.04 and as low as $7.69.

The top ETF exchange traded funds that ASMB belongs to (by Net Assets): VTI, VXF, FESM, AVUV, IWC.

ASMB has underperformed the market in the last year with a price return of +22.3% while the SPY ETF gained +23.8%. ASMB has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -20.8% and -3.2%, respectively, while the SPY returned +3.7% and +1.4%, respectively.

ASMB support price is $13.26 and resistance is $14.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASMB shares will trade within this expected range on the day.